Endpoints' Drew Armstrong and FTC deputy director Rahul Rao at the Financial Times' US Pharma and Biotech Summit (Sarah Merians Photography for Endpoints News)

Q&A: FTC’s top health­care en­forcer on phar­ma M&A, com­pa­ny growth and PBMs

The Fed­er­al Trade Com­mis­sion has loomed large over M&A in the bio­phar­ma in­dus­try in the last two years. The an­titrust reg­u­la­tor at­tempt­ed to block Am­gen …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.